Novavax shares were rising Friday after the vaccine maker and the Serum Institute of India were issued an emergency use authorization for their Covid-19 vaccine by the World Health Organization on Friday.
The WHO granted emergency-use status for Covovax, which is manufactured and marketed by the Serum Institute for India and certain other developing countries.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.